A Contact-Free Optical Device for the Detection of Pulmonary Congestion-A Pilot Study.
camera
congestion
contact-free
heart failure
increased lung fluid content
remote monitoring
Journal
Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191
Informations de publication
Date de publication:
06 Oct 2022
06 Oct 2022
Historique:
received:
25
07
2022
revised:
29
09
2022
accepted:
30
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
The cost of heart failure hospitalizations in the US alone is over USD 10 billion per year. Over 4 million Americans are hospitalized every year due to heart failure (HF), with a median length of stay of 4 days and an in-hospital mortality rate that exceeds 5%. Hospitalizations of patients with HF can be prevented by early detection of lung congestion. Our study assessed a new contact-free optical medical device used for the early detection of lung congestion. The Gili system is an FDA-cleared device used for measuring chest motion vibration data. Lung congestion in the study was assessed clinically and verified via two cardiologists. An algorithm was developed using machine learning techniques, and cross-validation of the findings was performed to estimate the accuracy of the algorithm. A total of 227 patients were recruited (101 cases vs. 126 controls). The sensitivity and specificity for the device in our study were 0.91 (95% CI: 0.86-0.93) and 0.91 (95% CI: 0.87-0.94), respectively. In all instances, the observed estimates of PPVs and NPVs were at least 0.82 and 0.90, respectively. The accuracy of the algorithm was not affected by different covariates (including respiratory or valvular conditions). This study demonstrates the efficacy of a contact-free optical device for detecting lung congestion. Further validation of the study results across a larger and precise scale is warranted.
Sections du résumé
BACKGROUND
BACKGROUND
The cost of heart failure hospitalizations in the US alone is over USD 10 billion per year. Over 4 million Americans are hospitalized every year due to heart failure (HF), with a median length of stay of 4 days and an in-hospital mortality rate that exceeds 5%. Hospitalizations of patients with HF can be prevented by early detection of lung congestion. Our study assessed a new contact-free optical medical device used for the early detection of lung congestion.
METHODS
METHODS
The Gili system is an FDA-cleared device used for measuring chest motion vibration data. Lung congestion in the study was assessed clinically and verified via two cardiologists. An algorithm was developed using machine learning techniques, and cross-validation of the findings was performed to estimate the accuracy of the algorithm.
RESULTS
RESULTS
A total of 227 patients were recruited (101 cases vs. 126 controls). The sensitivity and specificity for the device in our study were 0.91 (95% CI: 0.86-0.93) and 0.91 (95% CI: 0.87-0.94), respectively. In all instances, the observed estimates of PPVs and NPVs were at least 0.82 and 0.90, respectively. The accuracy of the algorithm was not affected by different covariates (including respiratory or valvular conditions).
CONCLUSIONS
CONCLUSIONS
This study demonstrates the efficacy of a contact-free optical device for detecting lung congestion. Further validation of the study results across a larger and precise scale is warranted.
Identifiants
pubmed: 36290968
pii: bios12100833
doi: 10.3390/bios12100833
pmc: PMC9599847
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Crit Care Resusc. 2016 Jun;18(2):124
pubmed: 27242110
Int J Cardiol. 2016 Oct 15;221:841-6
pubmed: 27434357
Circ Heart Fail. 2021 Apr;14(4):e008335
pubmed: 33866827
J Am Coll Cardiol. 2017 Oct 10;70(15):1875-1886
pubmed: 28982501
Int J Cardiol. 2014 Feb 15;171(3):368-76
pubmed: 24398230
Heart Fail Rev. 2021 Sep;26(5):1063-1080
pubmed: 32338334
JACC Heart Fail. 2020 Aug;8(8):692-694
pubmed: 32731947
J Clin Med. 2021 Oct 13;10(20):
pubmed: 34682813
Int J Cardiol Heart Vasc. 2021 Feb;32:100724
pubmed: 33532544
Opt Express. 2009 Nov 23;17(24):21566-80
pubmed: 19997398
Circ Heart Fail. 2018 Dec;11(12):e004873
pubmed: 30562099
Eur J Heart Fail. 2022 Mar;24(3):565-577
pubmed: 34617373
Sensors (Basel). 2017 Jan 12;17(1):
pubmed: 28085085
Respir Care. 2018 Nov;63(11):1379-1387
pubmed: 30087195
Curr Heart Fail Rep. 2012 Dec;9(4):346-53
pubmed: 23070579
Respirology. 2019 Dec;24(12):1143-1151
pubmed: 30739370
ESC Heart Fail. 2021 Oct;8(5):3696-3708
pubmed: 34165912
Circ Heart Fail. 2018 Jul;11(7):e004669
pubmed: 30002113
Eur Heart J. 2016 Apr 14;37(15):1244-51
pubmed: 26819225
JACC Heart Fail. 2020 Jan;8(1):12-21
pubmed: 31606361
Curr Opin Cardiol. 2017 Mar;32(2):217-223
pubmed: 28059840
J Am Heart Assoc. 2017 Nov 29;6(12):
pubmed: 29187385
Front Cardiovasc Med. 2020 Dec 09;7:612818
pubmed: 33363223
Heart. 2021 Mar;107(5):366-372
pubmed: 33431425
Eur Heart J Suppl. 2020 Dec 23;22(Suppl Pt t):P29-P32
pubmed: 33390867
JACC Heart Fail. 2021 Dec;9(12):916-924
pubmed: 34857175
Curr Cardiol Rep. 2020 Nov 20;23(1):1
pubmed: 33216256
J Med Eng Technol. 2021 Jul;45(5):344-350
pubmed: 33849394
Can J Cardiol. 2022 Feb;38(2):279-291
pubmed: 34863912
Eur J Heart Fail. 2016 Mar;18(3):242-52
pubmed: 26727047
Eur Heart J. 2013 Mar;34(11):835-43
pubmed: 23293303
JMIR Mhealth Uhealth. 2019 Mar 27;7(3):e12284
pubmed: 30916656
Clin Cardiol. 2017 Jul;40(7):430-436
pubmed: 28272808
Card Fail Rev. 2017 Nov;3(2):116-121
pubmed: 29387464
Sensors (Basel). 2021 Jan 28;21(3):
pubmed: 33525556
JACC Heart Fail. 2019 Oct;7(10):849-858
pubmed: 31582107
Europace. 2019 Jan 01;21(1):41-47
pubmed: 30085018
Cardiol Rev. 2017 Mar/Apr;25(2):53-58
pubmed: 27465538
Am J Med. 2017 Nov;130(11):1326-1330
pubmed: 28756266
Intensive Care Med. 2020 Oct;46(10):1873-1883
pubmed: 32860069
Heart Lung Circ. 2005;14 Suppl 2:S31-3
pubmed: 16352285